Publications

Showing entries 81 - 100 out of 101

2014


Meier SM, Hanif M, Adhireksan Z, Pichler V, Novak M, Jirkovsky E et al. Novel Metal(II) Arene 2-Pyridinecarbothioamides (PCAs): A Rationale to Orally Active Organometallic Anticancer Agents. Journal of Biological Inorganic Chemistry. 2014;19(Suppl. 1):587. doi: https://doi.org/10.1007/s00775-014-1095-8

Fischer B, Heffeter P, Kryeziu K, Gille L, Meier SM, Berger W et al. Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activation. Dalton Transactions. 2014;43(3):1096-1104. doi: 10.1039/c3dt52388h

2013


Hartinger CG, Größl M, Meier SM, Casini A, Dyson PJ. Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs. Chemical Society Reviews. 2013;42(14):6186-6199. doi: 10.1039/c3cs35532b

Meier SM, Hanif M, Adhireksan Z, Pichler V, Novak M, Jirkovsky E et al. Novel metal(II) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents. Chemical Science. 2013;4(4):1837-1846. doi: 10.1039/c3sc22294b

2012


2011


Kandioller W, Kurzwernhart A, Meier SM, Keppler B, Hartinger C. Pyrone derivatives and metals: From natural products to metal-based drugs. Journal of Organometallic Chemistry. 2011;696(5):999-1010. doi: 10.1016/j.jorganchem.2010.11.010

Showing entries 81 - 100 out of 101